Publikation
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
Wissenschaftlicher Artikel/Review - 28.02.2018
Loibl Sibylle, Liu Xuan, Symmans W Fraser, Rastogi Priya, Metzger Filho Otto, Ponce Lorenzo Jose J, McIntyre Kristi, Wolmark Norman, Sullivan Danielle, Maag David, von Minckwitz Gunter, Golshan Mehra, Huober Jens, McKee Mark D, Rugo Hope S, Sikov William M, Untch Michael, O'Shaughnessy Joyce, Geyer Charles E
Loibl, Sibylle
84
0
O'Shaughnessy, Joyce
7
0
Untch, Michael
88
0
Sikov, William M
4
0
Rugo, Hope S
8
0
McKee, Mark D
1
0
Huober, Jens
Chefarzt/ChefärztinBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
291
11
Golshan, Mehra
4
0
von Minckwitz, Gunter
59
0
Maag, David
5
0
Sullivan, Danielle
1
0
Wolmark, Norman
8
0
McIntyre, Kristi
1
0
Ponce Lorenzo, Jose J
1
0
Metzger Filho, Otto
2
0
Rastogi, Priya
7
0
Symmans, W Fraser
3
0
Liu, Xuan
1
0
Geyer, Charles E
8
0